Drugs / P3914
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01339156 | Jun → Nov 2011 | — | Piramal Enterprises Limited | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P3914 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01339156 ↗ |
| Action | Inhibit | “COX inhibiting moiety” NCT01339156 ↗ |
| Route | Oral | “The drug will be administered orally to each subject in sitting posture.” NCT01339156 ↗ |